FDA Inspection 890883 — Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd. on July 16, 2014 in Fengxian District. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 16, 2014
- Fiscal Year
- 2014
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Fengxian District (China)